CCL5 and respiratory syncytial virus infectious disease: EVs produced during respiratory syncytial virus infection deliver viral components to stimulate monocytes and airway epithelial cells to produce chemokines such as MCP-1/IP-10/CCL5 and CCL5/IP-10/TNF-α, respectively, for counteracting infection.27